Edgewise Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Edgewise Therapeutics

10/08/2023 15:26

* Edgewise Therapeutics Inc  EWTX.OQ  reported a quarterly
adjusted loss of 34 cents​​ per share for the quarter ended in
June. The mean expectation of five analysts for the quarter was
for a loss of 40 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Edgewise Therapeutics Inc's reported EPS for the quarter
was a
loss of 34 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4.7%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Edgewise Therapeutics Inc shares had fallen by 16.3% this
quarter and lost 27.4% so far this year.
    * The company reported a quarterly loss of $21.47 million.
    * Wall Street's median 12-month price target for Edgewise
Therapeutics Inc is $27.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 10 at 02:26 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.40          -0.34          Beat
 Mar. 31 2023      -0.36          -0.36          Met
 Dec. 31 2022      -0.34          -0.31          Beat
 Sep. 30 2022      -0.36          -0.34          Beat